POWAY, Calif., June 01, 2026 (GLOBE NEWSWIRE) — Diazyme Laboratories, Inc. announced today that it has acquired the business of Carolina Liquid Chemistries Corporation (CLC). CLC is an FDA registered manufacturer, and value-added reseller of chemistry systems and reagents. Founded in 1994 and headquartered in Greensboro, North Carolina, CLC’s business will be integrated into Diazyme’s operations. “Carolina Liquid Chemistries’ cost-effective and reliable products will complement Diazyme’s proprietary enzyme and immunoassay technologies, creating synergies that will benefit laboratories of all sizes,” said Dr. Chong Yuan, Managing
Director of Diazyme Laboratories. “This strategic acquisition positions us to enhance our diagnostic capabilities and deliver even more comprehensive solutions to reference and clinical laboratories and improve patient outcomes.” About Diazyme Laboratories, Inc. Diazyme Laboratories, Inc. is located in Poway, California. Diazyme uses its proprietary enzyme and immunoassay technologies to develop diagnostic test reagents run on automated chemistry analyzers and chemiluminescence instruments in user-friendly formats. Diazyme is a cGMP and ISO 13485 certified medical device manufacturer. Information regarding Diazyme’s technology and products can be found
on its website at www.diazyme.com. For Further Information Contact: SalesTel: 858-455-4768Email: Sales@Diazyme.com
Diazyme Laboratories, Carolina Liquid Chemistries, CLC, acquisition, diagnostic test reagents, enzyme and immunoassay technologies, chemistry systems and reagents, FDA registered manufacturer, Poway, Greensboro, cGMP, ISO 13485
So is this like a buyout for lab tests or something?
“Synergies” 🙄 but ok. If they’re FDA registered I guess it’s fine? I just hope it doesn’t make tests more expensive for regular labs.
Wait, Carolina Liquid Chemistries was in Greensboro right, so does that mean Greensboro labs lose their jobs or are they moving to Poway? The article makes it sound like “integrated” but nobody says what happens to people.
I don’t even get why they need an acquisition for enzymes and immunoassay stuff, can’t they just make their own reagents? Also “patient outcomes” sounds like marketing to me. Feels like another corporate merger where the lab techs do all the work and the executives say it helps patients.